Polish Pharma Co. Gets Arbitration Bid OK'd In IP Fight

By Caroline Simson (September 17, 2021, 5:54 PM EDT) -- A North Carolina judge has signed off on a bid by a Polish pharmaceuticals manufacturer to force arbitration in Switzerland of a dispute over trade secrets relating to a muscle relaxant, rejecting an argument that the company had waived arbitration by seeking an injunction first.

U.S. District Judge Max O. Cogburn Jr. on Thursday denied the motion by a U.S. company, Kartha Pharmaceuticals Inc., seeking to bar Zaklady Farmaceutyczne Polpharma SA from pursuing the arbitration, saying it didn't matter that the Polish company had asked a court for an injunction barring Kartha from disclosing or using the trade secrets before kicking...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!